---
name: Adragos Pharma
slug: adragos-pharma
site: cdmo
website_domain: adragos-pharma.com
summary: Global CDMO Headquartered in Munich, Germany.
tagline: End-to-end CDMO partner for small molecules and biologics across seven global facilities.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: DD
tier2_domain_verified: false
updated_at: 2026-08-23T07:02:32.334Z
services_count: 17
modalities_count: 2
indications_count: 1
locations_count: 8
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Adragos Pharma

End-to-end CDMO partner for small molecules and biologics across seven global facilities.

Listed on cdmo.directory.

## Summary

Global CDMO Headquartered in Munich, Germany.

## At a glance

- HQ country: DD

## Services

- Formulation Development
- CMC Analytical Development
- Process Development
- Stability Testing & Storage
- Quality Control Testing
- CMC Regulatory Submission Support
- HPAPI Manufacturing (High-Potency)
- Lyophilization (Freeze Drying)
- Prefilled Syringe (PFS) Filling
- Vial Filling
- Sterile Fill-Finish & Aseptic Manufacturing
- Oral Solid Dosage Manufacturing
- Topical & Semi-Solid Manufacturing
- Cold-Chain Storage & Logistics
- Secondary Packaging & Labeling
- Technology Transfer
- Monoclonal Antibody (mAb) Manufacturing

## Modalities

- Biologics (Monoclonal Antibodies)
- Small Molecule

## Indications

- Women's Health

## Locations

- Headquarters, Munich, Bavaria, Germany
- Development & Manufacturing, Athens, Attica, Greece
- Manufacturing, Halden, Østfold, Norway
- Manufacturing, Jura, Bourgogne-Franche-Comté, France
- Manufacturing, Kawagoe, Saitama, Japan
- Manufacturing, Livron, Auvergne-Rhône-Alpes, France
- Manufacturing, Leipzig, Saxony, Germany
- Manufacturing, Maisons-Alfort, Île-de-France, France

## Long description

Adragos Pharma is a Contract Development and Manufacturing Organisation (CDMO) with a global presence spanning Europe, Japan, and North America. The company operates an integrated network of seven strategically located facilities (Athens, Halden, Jura, Kawagoe, Livron, Leipzig, and Maisons-Alfort) dedicated to delivering end-to-end pharmaceutical development and manufacturing services.

## Core Capabilities

**Drug Development & Formulation**
- Formulation development across multiple dosage forms
- Analytical development and method development
- Clinical development support
- Expertise in HPAPI (highly potent active pharmaceutical ingredients)
- Process development and optimization

**Manufacturing Services**
- **Sterile Liquids:** vials, ampoules, IV bags, prefilled syringes
- **Non-Sterile Liquids:** oral solutions, oral drops, suspensions, emulsions, disinfection products
- **Semi-Solids:** creams, ointments, gels, healing pastes
- **Oral Solids:** suppositories and other solid dosage forms
- Aseptic filling and lyophilization capabilities
- Commercial manufacturing at scale

**Clinical & Regulatory Support**
- Preclinical material preparation
- Clinical supply manufacturing with GMP compliance
- Regulatory affairs and CMC support
- Supply chain planning and cold chain management
- Drug stability testing
- Visual inspection and pharmaceutical packaging
- Out-licensing services

## Regulatory Compliance

Adragos Pharma adheres to standards set by the FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and PMDA (Pharmaceuticals and Medical Devices Agency in Japan). The company implements rigorous quality control and assurance measures throughout development and manufacturing to ensure global market compliance.

## Differentiation

The company emphasizes a customer-centric approach with dedicated project managers, flexible timelines, and seamless coordination across its global network. Client testimonials highlight technical expertise in complex formulations, transparency in quotations, and ability to advance projects from concept to registered marketable product on budget and on time.

## Related companies

- [Delpharm](/companies/delpharm) (Formulation Development, Process Development) — [Compare](/compare/adragos-pharma/delpharm)
- [Pharmaceutics International, Inc.](/companies/pharm-int) (Formulation Development, CMC Analytical Development) — [Compare](/compare/adragos-pharma/pharm-int)
- [Bend Bioscience](/companies/bend-bioscience) (Formulation Development, CMC Analytical Development) — [Compare](/compare/adragos-pharma/bend-bioscience)
- [Vetter Pharma](/companies/vetter-pharma) (Formulation Development, CMC Analytical Development) — [Compare](/compare/adragos-pharma/vetter-pharma)
- [Ascendia Pharmaceutical Solutions](/companies/ascendiacdmo) (Formulation Development, CMC Analytical Development) — [Compare](/compare/adragos-pharma/ascendiacdmo)
- [Pfizer CentreOne](/companies/pfizercentreone) (Formulation Development, CMC Analytical Development) — [Compare](/compare/adragos-pharma/pfizercentreone)
- [Akums Drugs and Pharmaceuticals Ltd.](/companies/akums) (Formulation Development, CMC Analytical Development) — [Compare](/compare/adragos-pharma/akums)
- [UPM Pharmaceuticals](/companies/upm-inc) (Formulation Development, CMC Analytical Development) — [Compare](/compare/adragos-pharma/upm-inc)

_Profile last updated: 2026-08-23T07:02:32.334Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.